Professor Tom Crosby OBE
Tom is a Consultant Oncologist in Velindre Cancer Centre, specialising in Upper GI cancer since 2008.
As clinical lead for the Wales Cancer Network Tom lead the development of the Cancer Delivery Plan 2016-20, Peer Review of Cancer Services in Wales and the Cancer Implementation Group’s prioritisation programme including the development of Cancer Prevention, Early Diagnosis, Person Centred Care and Cancer Information Subgroups. He is also helping to lead the development a new Cancer Research Strategy for Wales and a new Velindre Cancer |Centre in Cardiff. He currently leads a priority initiative in Wales: the Single Cancer Pathway which looks to transform patient pathways from referral, through diagnosis to treatment.
Tom is a leader in Upper GI Oesophageal Chemo-radiotherapy Research, Service and Development in the UK. He is Chief Investigator to the series of UK Multi-centre SCOPE trials (SCOPE1, NeoSCOPE and SCOPE2). He was the recent Chair of the NCRI OG Cancer Subgroup.
He was Lead of the inaugural RCR Site Oriented e-Network and is the current Welsh and Oncology Lead for the UK National Oesophago-Gastric Cancer Audit.
Tom has been an examiner for the Royal College Radiologists Part 2 Exam and is the Chair of the Cardiff FRCR 2 Course a lead author of the textbook Practical Clinical Oncology (Cambridge University Press).
Tom is currently the clinical lead for the Transformation of Cancer Services Programme in South East Wales. This ambitious programme will seek to develop a new world class Velindre Cancer Centre and redesign the clinical service model to meet the demands of future care and improve outcomes for patients.
Tom has recently been recognised for his service to cancer services in Wales and the UK with the award of an honorary Professorship by Cardiff University and an OBE in the New Year’s Honours list and is now the National Clinical Director of Cancer for Wales.
As clinical lead for the Wales Cancer Network Tom lead the development of the Cancer Delivery Plan 2016-20, Peer Review of Cancer Services in Wales and the Cancer Implementation Group’s prioritisation programme including the development of Cancer Prevention, Early Diagnosis, Person Centred Care and Cancer Information Subgroups. He is also helping to lead the development a new Cancer Research Strategy for Wales and a new Velindre Cancer |Centre in Cardiff. He currently leads a priority initiative in Wales: the Single Cancer Pathway which looks to transform patient pathways from referral, through diagnosis to treatment.
Tom is a leader in Upper GI Oesophageal Chemo-radiotherapy Research, Service and Development in the UK. He is Chief Investigator to the series of UK Multi-centre SCOPE trials (SCOPE1, NeoSCOPE and SCOPE2). He was the recent Chair of the NCRI OG Cancer Subgroup.
He was Lead of the inaugural RCR Site Oriented e-Network and is the current Welsh and Oncology Lead for the UK National Oesophago-Gastric Cancer Audit.
Tom has been an examiner for the Royal College Radiologists Part 2 Exam and is the Chair of the Cardiff FRCR 2 Course a lead author of the textbook Practical Clinical Oncology (Cambridge University Press).
Tom is currently the clinical lead for the Transformation of Cancer Services Programme in South East Wales. This ambitious programme will seek to develop a new world class Velindre Cancer Centre and redesign the clinical service model to meet the demands of future care and improve outcomes for patients.
Tom has recently been recognised for his service to cancer services in Wales and the UK with the award of an honorary Professorship by Cardiff University and an OBE in the New Year’s Honours list and is now the National Clinical Director of Cancer for Wales.
